March 3, 2019 - Parkinson's Weekly Update

March 3, 2019 – Parkinson’s Weekly Update

This is a recap of the most interesting news and discussions relating to Parkinson’s Disease this past week. There was a lot of talk last week about the results of the Parkinson’s Disease trial in the UK involving a surgery that implanted tubes in patients’ heads that could be used post-surgery to deliver GDNF and would hopefully regenerate dying dopamine brain cells. On, the other side of the pond, the FDA is allowing a Fecal Microbiota Transplantation (yes, we’re talking about poop transplants) study to include Parkinson’s. Meanwhile in California, a stem cell PD trial moves closer to FDA approval. And ...
FDA allows Fecal Microbiota Transplantation (FMT) study to include Parkinson’s

FDA allows Fecal Microbiota Transplantation (FMT) study to include Parkinson’s

Local TV news station KHOU (channel 11) in Houston is reporting that the FDA has given the green light to expand a Fecal Microbiota Transplantation (FMT) study at UTHealth to include Parkinson’s. https://www.khou.com/article/news/health/doctors-use-human-feces-to-treat-deadly-disease/285-86b1359c-51c4-4d12-b428-0cfa84215b1a The study is being performed at the Kelsey Research Foundation UTHealth Center for Microbiome Research in Houston, Texas. The idea behind FMT is that good bacteria in healthy stool samples is transferred to an unhealthy individual to repair whatever is going wrong in the gut. In a UTHealth lab, the stool samples are mixed with saline, filtered twice, freeze dried, then put in capsules. The basic transplant takes place in ...